{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T23:34:53Z","timestamp":1715211293654},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> The availability of several biological therapy options is rapidly growing in the field of malignant lymphomas. This emphasizes the need to understand the precise interaction of the host immune system with the malignant disease. We measured the intracellular cytokine responses in lymphoma patients\u2019 lymphocytes, to characterize the polarization changes in their immune system.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Patients with B cell non\u2010Hodgkin's lymphoma were involved in the study. Peripheral lymphocytes were labeled with anti\u2010CD4 or anti\u2010CD8 antibodies and intracellular accumulation of IL\u20104 or IFN\u2010<jats:italic>\u03b3<\/jats:italic> was detected after <jats:italic>in vitro<\/jats:italic> incubation the cells with activating cocktail. The frequency of different T\u2010cell subsets were measured within the lymphocyte population.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Significantly increased CD4+, IFN\u2010<jats:italic>\u03b3<\/jats:italic> producing (Th1) cell percentage were found in untreated lymphoma cases (28.8% vs. 21.8%). CD8+ IL\u20104 and IFN\u2010<jats:italic>\u03b3<\/jats:italic> producing (Tc0) T cell frequency is significantly higher in untreated lymphoma patients compared with normal controls (1.3% vs. 0.47%). The frequency of CD4+ IL\u20104 producing (Th2) cells is significantly lower in untreated patients (0.96% vs. 1.19%). Patients in long\u2010term remission have lower frequency of CD4+, IL4 producing (Th2) cell ratio (0.31% vs. 1.19%) and increased CD4+ IFN\u2010<jats:italic>\u03b3<\/jats:italic> producing (Th1) cell frequency (30.1% vs. 21.8%), compared with healthy normal controls.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Our results demonstrate that there is a sustained increase in the CD4+ IFN\u2010<jats:italic>\u03b3<\/jats:italic> producing cell frequency in lymphoma patients. The frequency of CD4+ IL\u20104 producing cells is decreasing by treatment. These may contribute to strong polarization toward Th1 type response, needed for lymphoma clearance and remission.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2004.00234.x","type":"journal-article","created":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T15:43:58Z","timestamp":1080834238000},"page":"336-341","source":"Crossref","is-referenced-by-count":7,"title":["Intracellular IL\u20104\/IFN\u2010gamma producing peripheral T lymphocyte subsets in B cell non\u2010Hodgkin's lymphoma patients"],"prefix":"10.1111","volume":"72","author":[{"given":"Lajos","family":"Gergely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdolna","family":"Aleksza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e1r\u00f3czy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ponyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Sipka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1rp\u00e1d","family":"Ill\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.231"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/13684730412331302063"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01582.x"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.4.1611.1611_1611_1617"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520152584842"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(01)00174-8"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.67"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363080-00005"},{"key":"e_1_2_9_10_2","first-page":"951","article-title":"Clinical activity and safety of combination immunotherapy with IFN\u2010alpha 2a and rituximab in patients with relapsed low grade non\u2010Hodgkin's lymphoma","volume":"86","author":"Sacchi S","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-001-0237-3"},{"key":"e_1_2_9_12_2","first-page":"2644","article-title":"Combination immunotherapy of relapsed or refractory low\u2010grade or follicular non\u2010Hodgkin's lymphoma with rituximab and interferon\u2010alpha\u20102a","volume":"6","author":"Davis TA","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(93)90158-4"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.05013.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2359::AID-CNCR10>3.0.CO;2-A"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290026385"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-001-0232-8"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00194-1"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01612.x"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02525.x"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.10041"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5405.1183"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-57276-0_19"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000090246"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.5.2498"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2004.00234.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2004.00234.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2004.00234.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:12:09Z","timestamp":1697202729000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2004.00234.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1600-0609.2004.00234.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2004.00234.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}